Gregg Philip Moody, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15242 Greenfield Dr, Athens, AL 35613 Phone: 256-233-2914 Fax: 256-230-9005 |
News Archive
During the G20 summit opening Thursday in Pittsburgh, President Obama will propose countries around the world phase out government subsidies that promote the production and use of fossil fuels "that spew carbon dioxide, the chief greenhouse gas," the Associated Press reports (Borenstein, 9/23).
Survey results released by the American College of Preventive Medicine (ACPM) found that nearly half (48%) of U.S. adults 40+ with diabetes are not utilizing aspirin therapy to reduce their risk of recurrent heart attack or stroke nor had they reported discussing such therapy with their healthcare provider.
Portola Pharmaceuticals, Inc. today announced that it has initiated its first in human Phase 1 trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In preclinical in vivo models of RA, PRT062607 was shown to reduce inflammation in a dose-dependent manner.
Echocardiography is a test that uses ultrasound techniques to produce images of the heart in real time. Stress echocardiography uses this technique to evaluate the heart rate response while performing an activity in which the heart has to work (stress).
The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration's decision to grant approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of death in infants.
› Verified 6 days ago